Detalhe da pesquisa
1.
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452207
2.
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Blood
; 142(21): 1806-1817, 2023 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595275
3.
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Blood
; 139(24): 3505-3518, 2022 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316324
4.
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Blood
; 138(19): 1855-1869, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125178
5.
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica
; 108(12): 3287-3297, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891751
6.
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Blood
; 136(3): 328-338, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321172
7.
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL.
Haematologica
; 107(9): 2072-2080, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263986
8.
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
N Engl J Med
; 375(11): 1044-53, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626518
9.
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.
Blood
; 130(16): 1832-1844, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28790105
10.
DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.
Haematologica
; 104(8): 1617-1625, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655366
11.
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Blood
; 125(24): 3711-9, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878120
12.
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
Blood
; 125(16): 2486-96; quiz 2586, 2015 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587040
13.
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.
Blood
; 133(3): 280-284, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510083
14.
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.
Blood
; 123(24): 3739-49, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740809
15.
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Am J Hematol
; 90(11): 986-91, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214580
16.
PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax.
Clin Cancer Res
; 30(1): 94-105, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889114
17.
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Blood
; 118(19): 5099-107, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21835957
18.
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
Blood Cancer Discov
; 4(2): 134-149, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630200
19.
Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study.
Leuk Lymphoma
; 61(9): 2161-2167, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508181
20.
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
Leukemia
; 34(7): 1730-1740, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992840